查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826799

2025年介入性神经放射学全球市场报告

Interventional Neuroradiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，介入性神经放射学市场规模强劲成长，从2024年的19.4亿美元增加至2025年的20.5亿美元，复合年增长率为5.9%。预测期内的增长可归因于导管介入治疗的广泛接受、医疗基础设施的不断扩展、高血压盛行率的上升、糖尿病盛行率的上升以及远端医疗的扩展。

介入性神经放射学市场预计将在未来几年强劲成长，到2029年将达到25.9亿美元，复合年增长率为5.9%。预测期内的增长归因于液体栓塞剂的引入、血管内治疗方法的普及、机械性切除术的普及、对可拆卸栓塞线圈的依赖性不断增强以及生物可吸收支架的广泛应用。预测期内的主要趋势包括导航系统的进步、渗透性支援设备的创新、人工智慧在神经影像设备中的整合、血栓除去装置的最佳化以及介入设备中的人工智慧干预。

介入性神经放射学 (INR) 是一门专注于使用微创技术诊断和治疗影响大脑、脊椎和血管的神经系统疾病的医学专业。此方法使用先进的影像技术来指导导管介入、血管成形术、置入术和栓塞术等手术。

介入性神经放射学的主要器械包括微导管、神经血管栓塞和栓塞辅助装置、栓塞线圈、血流转向装置、液体栓塞剂、附件和导管导引线。微导管是一种细而柔韧的管状器械，用于进入脑部和脊椎复杂的细小血管。这些器械用于治疗脑动脉瘤、颅内肿瘤和急性中风，并应用于各种环境，包括医院、门诊手术中心和诊断中心。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗机构正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，其中许多产品的国内替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原材料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供介入神经放射学市场统计数据，例如介入神经放射学行业的全球市场规模、各地区市场份额、介入神经放射学市场份额的竞争对手、介入神经放射学细分市场的详细情况、市场趋势和商机，以及您在介入神经放射学行业取得成功所需的数据。本介入性神经放射学市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年5.9%的成长率预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国，包括增加来自法国和爱尔兰的神经血管支架和血流改道装置的成本、推迟卒中干预措施以及增加介入神经放射学实验室的成本。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

神经系统疾病盛行率的不断上升预计将推动介入神经放射学市场的成长。这些影响大脑、脊髓和周边神经的疾病会损害运动、感觉、认知和沟通。神经系统疾病的增加主要是由于全球人口老化，这增加了阿兹海默症与老龄化相关的疾病的风险。诊断技术的进步也使得更早、更准确地发现这些疾病成为可能。介入性神经放射学使用微创、影像导引技术来诊断和治疗动脉瘤、中风和动静脉畸形等疾病。例如，英国阿兹海默症研究中心在 2023 年 5 月报告称，失智症是 2022 年英国的主要死因，死亡人数超过 74,000 人，比前一年增加了 5,000 人。因此，神经系统疾病的增加正在推动介入神经放射学市场的成长。

介入性神经放射学市场的主要参与者正致力于开发先进的解决方案，例如头部固定装置，以改善神经放射学和介入放射学手术中的影像品质和病人安全。头部固定装置是用于暂时固定患者头部和颈部的医疗设备，主要用于在疑似头部或脊椎损伤的情况下确保安全和稳定。例如，2023年6月，纽西兰製造商Adept Medical推出了一款新型头部固定装置，以提高患者在手术过程中的舒适度和影像品质。该装置采用真空吸力技术，可牢固地固定头部；其渗透性的设计可最大限度地减少对X射线成像的干扰；并且兼容各种成像台。它还透过快速设定提高了工作流程效率，并适应各种头型，确保患者的舒适度。

2023年1月，美国医疗保健公司GE医疗科技收购了法国医疗技术公司IMACTIS，后者专注于导航系统用电脑断层扫描技术。收购条款尚未披露。 GE医疗希望透过此次收购，整合CT导航技术，改善介入引导的传递，提高手术准确性，减少差异性，并扩展其在介入放射学领域的能力。此次收购也旨在将IMACTIS的解决方案拓展到各个医疗领域。

介入性神经放射学市场由提供栓塞术、球囊血管成形术、血管内卷取和机械血栓切除术等服务的营业单位所获得的收益所构成。市场价值包括服务提供者销售或包含在其服务产品中的相关商品的价值。介入性神经放射学市场还包括栓塞剂、导管导引线、显微手术器械和神经血管导管的销售。该市场中的商品价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球介入性神经放射学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球介入性神经放射学市场：成长率分析
  • 全球介入性神经放射学市场表现：规模与成长，2019-2024
  • 全球介入性神经放射学市场预测：2024-2029年及2034年规模与成长
  • 全球介入神经放射学：总目标市场（TAM）

第六章 市场细分

  • 全球介入性神经放射学市场（按设备类型）：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 微导管
  • 神经血管栓塞及线圈栓塞辅助装置
  • 栓塞线圈
  • 导流装置
  • 液态栓塞剂
  • 配件
  • 导管导引线
  • 全球介入性神经放射学市场：依疾病、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 脑动脉瘤
  • 颅内肿瘤
  • 急性中风
  • 其他疾病
  • 全球介入性神经放射学市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 诊断中心
  • 全球介入性神经放射学市场：按微导管类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 单腔微导管
  • 双腔微导管
  • 高流量微导管
  • 全球介入性神经放射学市场：神经血管栓塞和线圈栓塞辅助装置的细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 线圈辅助装置
  • 栓塞辅助装置
  • 全球介入性神经放射学市场：栓塞线圈细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 软线圈
  • 硬线圈
  • 可拆卸线圈
  • 全球介入性神经放射学市场：按流量分流装置细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于支架的血流改道装置
  • 无支架血流改道装置
  • 全球介入性神经放射学市场：液体栓塞剂细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基液态栓塞剂
  • 凝胶基液态栓塞剂
  • Onyx液体栓塞剂
  • 全球介入性神经放射学市场：依配件（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 引导管
  • 鞘套导引器
  • 静脉通路装置
  • 全球介入性神经放射学市场：按导管导引线类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 亲水性导管导引线
  • 可推导管导引线
  • 涂层导管导引线

第七章 区域和国家分析

  • 全球介入性神经放射学市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
  • 全球介入性神经放射学市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 介入性神经放射学市场：竞争格局
  • 介入性神经放射学市场：公司简介
    • Bayer HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Philips Healthcare
  • Stryker Corporation
  • GE Healthcare Life Sciences
  • Boston Scientific Corporation
  • Terumo Corporation
  • Canon Medical Systems Corporation
  • WL Gore & Associates Inc.
  • Teleflex Incorporated
  • Cook Medical LLC
  • Biotronik SE & Co. KG
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Guerbet Group
  • Mediterra LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年介入性神经放射学市场：提供新机会的国家
  • 2029年介入性神经放射学市场：细分领域带来新机会
  • 2029年介入性神经放射学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33783u

Interventional neuroradiology (INR) is a specialized medical field that focuses on the use of minimally invasive techniques to diagnose and treat neurological conditions affecting the brain, spine, and blood vessels. This approach employs advanced imaging methods to guide procedures such as catheter-based treatments, angioplasties, stent placements, and embolization.

The primary devices used in interventional neuroradiology include microcatheters, neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, and micro guidewires. Microcatheters are thin, flexible tubes designed to navigate intricate and small blood vessels in the brain and spine during procedures. These devices are utilized in treating conditions such as cerebral aneurysms, intracranial tumors, acute strokes, and others, with applications across various settings such as hospitals, ambulatory surgical centers, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The interventional neuroradiology market research report is one of a series of new reports from The Business Research Company that provides interventional neuroradiology market statistics, including interventional neuroradiology industry global market size, regional shares, competitors with an interventional neuroradiology market share, detailed interventional neuroradiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neuroradiology industry. This interventional neuroradiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional neuroradiology market size has grown strongly in recent years. It will grow from $1.94 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to wider acceptance of catheter-based intervention, expanding healthcare infrastructure, rising prevalence of hypertension, rising prevalence of diabetes, and expansion of telemedicine.

The interventional neuroradiology market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to introduction of liquid embolic agent, adoption of endovascular treatment methods, rise in use of mechanical throbectomy, growing reliance on detachable embolic coils, and increasing deployment of bioresobable scaffolds. Major trends in the forecast period include advancements in navigation systems, innovations in radiolucent support devices, integration of artificial intelligence in neuroimaging devices, optimization of thrombectomy devices, and intervention of artificial intelligence in intervention devices.

The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of neurovascular stents and flow diversion devices sourced from France and Ireland, thereby delaying stroke interventions and elevating neurointerventional lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the interventional neuroradiology market. These disorders, which affect the brain, spinal cord, or peripheral nerves, can impair movement, sensation, cognition, or communication. The rise in neurological conditions is largely attributed to the aging global population, which heightens the risk of age-related diseases such as Alzheimer's. Additionally, advancements in diagnostic technologies enable earlier and more precise detection of these disorders. Interventional neuroradiology uses minimally invasive, image-guided methods to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For example, Alzheimer's Research UK reported in May 2023 that dementia was the leading cause of death in the UK in 2022, with over 74,000 deaths, reflecting a rise of 5,000 from the previous year. As a result, the increasing number of neurological disorders is fueling the growth of the interventional neuroradiology market.

Key players in the interventional neuroradiology market are focusing on developing advanced solutions such as head immobilizers to improve imaging quality and patient safety during neuroradiology and interventional radiology procedures. A head immobilizer is a medical device designed to temporarily immobilize a patient's head and neck, primarily for safety and stability when a head or spinal injury is suspected. For instance, in June 2023, Adept Medical, a New Zealand-based manufacturer, introduced a new head immobilizer that enhances patient comfort and imaging quality during these procedures. The device features vacuum suction technology for secure head fixation, a radiolucent design that minimizes interference with X-ray imaging, and compatibility with various imaging tables. Its quick setup process improves workflow efficiency, and its ability to accommodate different head shapes ensures patient comfort.

In January 2023, GE Healthcare Technologies Inc., a US-based healthcare company, acquired IMACTIS, a France-based medical technology company specializing in computed tomography for navigation systems. The terms of the acquisition were not disclosed. With this acquisition, GE Healthcare intends to improve its interventional guidance offerings by integrating CT-Navigation technology, thereby enhancing procedural accuracy, reducing variability, and expanding its capabilities in interventional radiology. This acquisition also aims to scale IMACTIS's solutions across various medical fields.

Major players in the interventional neuroradiology market are Bayer HealthCare, Abbott Laboratories, Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Biotronik SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, and Medico's Hirata Inc.

North America was the largest region in the interventional neuroradiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional neuroradiology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional neuroradiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional neuroradiology market consists of revenues earned by entities by providing services such as embolization procedures, balloon angioplasty, endovascular coiling, and mechanical thrombectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional neuroradiology market also includes sales of embolization agents, guidewires, microsurgical instruments, and neurovascular catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Neuroradiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Microcatheters; Neurovascular Embolization And Coiling Assist Devices; Embolic Coils; Flow Diversion Devices; Liquid Embolic Agents; Accessories; Micro Guidewires
  • 2) By Disease: Cerebral Aneurysms; Intra-Cranial Tumors; Acute Strokes; Other Diseases
  • 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers
  • Subsegments:
  • 1) By Microcatheters: Single-Lumen Microcatheters; Dual-Lumen Microcatheters; High-Flow Microcatheters
  • 2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices; Embolization Assist Devices
  • 3) By Embolic Coils: Soft Coils; Stiff Coils; Detachable Coils
  • 4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices; Non-Stent-Based Flow Diversion Devices
  • 5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents; Gel-Based Liquid Embolic Agents; Onyx Liquid Embolic Agents
  • 6) By Accessories: Guide Catheters; Sheath Introducers; Vascular Access Devices
  • 7) By Micro Guidewires: Hydrophilic Micro Guidewires; Pushable Micro Guidewires; Coated Micro Guidewires
  • Companies Mentioned: Bayer HealthCare; Abbott Laboratories; Medtronic PLC; Siemens Healthineers AG; Fujifilm Corporation; Philips Healthcare; Stryker Corporation; GE Healthcare Life Sciences; Boston Scientific Corporation; Terumo Corporation; Canon Medical Systems Corporation; W. L. Gore & Associates Inc.; Teleflex Incorporated; Cook Medical LLC; Biotronik SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Guerbet Group; Mediterra LLC; Acandis GmbH; Medico's Hirata Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Neuroradiology Market Characteristics

3. Interventional Neuroradiology Market Trends And Strategies

4. Interventional Neuroradiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Neuroradiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Neuroradiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Neuroradiology Market Growth Rate Analysis
  • 5.4. Global Interventional Neuroradiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Neuroradiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Neuroradiology Total Addressable Market (TAM)

6. Interventional Neuroradiology Market Segmentation

  • 6.1. Global Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microcatheters
  • Neurovascular Embolization And Coiling Assist Devices
  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Accessories
  • Micro Guidewires
  • 6.2. Global Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cerebral Aneurysms
  • Intra-Cranial Tumors
  • Acute Strokes
  • Other Diseases
  • 6.3. Global Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • 6.4. Global Interventional Neuroradiology Market, Sub-Segmentation Of Microcatheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Lumen Microcatheters
  • Dual-Lumen Microcatheters
  • High-Flow Microcatheters
  • 6.5. Global Interventional Neuroradiology Market, Sub-Segmentation Of Neurovascular Embolization And Coiling Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coiling Assist Devices
  • Embolization Assist Devices
  • 6.6. Global Interventional Neuroradiology Market, Sub-Segmentation Of Embolic Coils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Soft Coils
  • Stiff Coils
  • Detachable Coils
  • 6.7. Global Interventional Neuroradiology Market, Sub-Segmentation Of Flow Diversion Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stent-Based Flow Diversion Devices
  • Non-Stent-Based Flow Diversion Devices
  • 6.8. Global Interventional Neuroradiology Market, Sub-Segmentation Of Liquid Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Liquid Embolic Agents
  • Gel-Based Liquid Embolic Agents
  • Onyx Liquid Embolic Agents
  • 6.9. Global Interventional Neuroradiology Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guide Catheters
  • Sheath Introducers
  • Vascular Access Devices
  • 6.10. Global Interventional Neuroradiology Market, Sub-Segmentation Of Micro Guidewires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrophilic Micro Guidewires
  • Pushable Micro Guidewires
  • Coated Micro Guidewires

7. Interventional Neuroradiology Market Regional And Country Analysis

  • 7.1. Global Interventional Neuroradiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Neuroradiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Neuroradiology Market

  • 8.1. Asia-Pacific Interventional Neuroradiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Neuroradiology Market

  • 9.1. China Interventional Neuroradiology Market Overview
  • 9.2. China Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Neuroradiology Market

  • 10.1. India Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Neuroradiology Market

  • 11.1. Japan Interventional Neuroradiology Market Overview
  • 11.2. Japan Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Neuroradiology Market

  • 12.1. Australia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Neuroradiology Market

  • 13.1. Indonesia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Neuroradiology Market

  • 14.1. South Korea Interventional Neuroradiology Market Overview
  • 14.2. South Korea Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Neuroradiology Market

  • 15.1. Western Europe Interventional Neuroradiology Market Overview
  • 15.2. Western Europe Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Neuroradiology Market

  • 16.1. UK Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Neuroradiology Market

  • 17.1. Germany Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Neuroradiology Market

  • 18.1. France Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Neuroradiology Market

  • 19.1. Italy Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Neuroradiology Market

  • 20.1. Spain Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Neuroradiology Market

  • 21.1. Eastern Europe Interventional Neuroradiology Market Overview
  • 21.2. Eastern Europe Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Neuroradiology Market

  • 22.1. Russia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Neuroradiology Market

  • 23.1. North America Interventional Neuroradiology Market Overview
  • 23.2. North America Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Neuroradiology Market

  • 24.1. USA Interventional Neuroradiology Market Overview
  • 24.2. USA Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Neuroradiology Market

  • 25.1. Canada Interventional Neuroradiology Market Overview
  • 25.2. Canada Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Neuroradiology Market

  • 26.1. South America Interventional Neuroradiology Market Overview
  • 26.2. South America Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Neuroradiology Market

  • 27.1. Brazil Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Neuroradiology Market

  • 28.1. Middle East Interventional Neuroradiology Market Overview
  • 28.2. Middle East Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Neuroradiology Market

  • 29.1. Africa Interventional Neuroradiology Market Overview
  • 29.2. Africa Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Neuroradiology Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Neuroradiology Market Competitive Landscape
  • 30.2. Interventional Neuroradiology Market Company Profiles
    • 30.2.1. Bayer HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Neuroradiology Market Other Major And Innovative Companies

  • 31.1. Philips Healthcare
  • 31.2. Stryker Corporation
  • 31.3. GE Healthcare Life Sciences
  • 31.4. Boston Scientific Corporation
  • 31.5. Terumo Corporation
  • 31.6. Canon Medical Systems Corporation
  • 31.7. W. L. Gore & Associates Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Cook Medical LLC
  • 31.10. Biotronik SE & Co. KG
  • 31.11. Merit Medical Systems Inc.
  • 31.12. MicroPort Scientific Corporation
  • 31.13. Penumbra Inc.
  • 31.14. Guerbet Group
  • 31.15. Mediterra LLC

32. Global Interventional Neuroradiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Neuroradiology Market

34. Recent Developments In The Interventional Neuroradiology Market

35. Interventional Neuroradiology Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Neuroradiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Neuroradiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Neuroradiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer